Bactiguard Holding AB has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), announced on 4 February 2020. The first part of the consideration, a cash payment of USD 4.5 million, has been paid, with the remainder in shares subject to shareholder approval.
Bactiguard acquired Malaysian manufacturer Vigilenz Medical Devices and Vigilenz Medical Supplies for USD 4.5 million cash and shares worth USD 2 million, strengthening its position in infection control and wound management.
Bactiguard received a new order from Well Lead Medical in China worth approximately SEK 16.5 million (EUR 1.6 million). The order will be delivered promptly and generate revenues in the fourth quarter of 2019.
Bactiguard entered into an exclusive global license agreement with Zimmer Biomet to use Bactiguard's infection prevention coating on orthopedic trauma implants. The agreement includes a $3 million upfront payment and up to $2 million in contingent payments plus royalties.
Bactiguard received a third major order from its distributor Jian An Pharmaceuticals for 100,000 Bactiguard coated Foley catheters for infection prevention, generating approximately 3 million SEK in revenue, to be delivered in June 2017.